Snyder Capital Management L P Boosts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Snyder Capital Management L P increased its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 6.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,194,802 shares of the company’s stock after purchasing an additional 69,835 shares during the quarter. Henry Schein comprises about 1.7% of Snyder Capital Management L P’s holdings, making the stock its 21st largest position. Snyder Capital Management L P owned 0.96% of Henry Schein worth $82,680,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HSIC. Versant Capital Management Inc grew its holdings in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC grew its stake in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the period. Finally, City State Bank purchased a new stake in Henry Schein in the 4th quarter worth approximately $55,000. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Trading Up 1.1 %

HSIC stock opened at $66.23 on Friday. The company has a market capitalization of $8.11 billion, a PE ratio of 27.26, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company’s 50 day moving average price is $69.46 and its two-hundred day moving average price is $71.81.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the previous year, the business earned $0.66 EPS. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. StockNews.com lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Barrington Research reiterated an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.